|
|
Found results for
patents
1.
|
ICE-FREE VITRIFICATION AND NANO-WARMING OF LARGE TISSUE SAMPLES
| Application Number |
19310608 |
| Status |
Pending |
| Filing Date |
2025-08-26 |
| First Publication Date |
2025-12-11 |
| Owner |
TISSUE TESTING TECHNOLOGIES LLC (USA)
|
| Inventor |
- Brockbank, Kelvin Gm
- Chen, Zhen Zhen
|
Abstract
Large volume cellular material may be preserved by combining the cellular material with a cryoprotectant formulation/medium/solution containing at least one mNP and then subjecting the cellular material to a vitrification preservation protocol including nanowarming. This preservation method is particularly effective for cartilage tissues.
IPC Classes ?
- A01N 1/125 - Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
|
2.
|
PRESERVATION OF NATURAL AND BIONENGINEERED TISSUES AND METHODS OF STORING AND TRANSPORT
| Application Number |
US2022049930 |
| Publication Number |
2023/086664 |
| Status |
In Force |
| Filing Date |
2022-11-15 |
| Publication Date |
2023-05-19 |
| Owner |
TISSUE TESTING TECHNOLOGIES LLC (USA)
|
| Inventor |
- Campbell, Lia H.
- Brockbank, Kelvin G.M.
|
Abstract
Described herein are methods for preserving biomaterials by vitrification while reducing or preventing the loss of viability associated with conventional preservation methods. Also described herein are cassettes and methods for using these cassettes for cryopreserving biomaterials (e.g., a bioengineered construct or natural tissue sample).
|
3.
|
CASSETTE FOR PRESERVATION OF NATURAL AND BIOENGINEERED TISSUES
| Application Number |
US2022049939 |
| Publication Number |
2023/086668 |
| Status |
In Force |
| Filing Date |
2022-11-15 |
| Publication Date |
2023-05-19 |
| Owner |
TISSUE TESTING TECHNOLOGIES LLC (USA)
|
| Inventor |
- Campbell, Lia H.
- Wright, Gregory J.
- Greene, Elizabeth
- Brockbank, Kelvin G.M.
|
Abstract
Described herein are cassettes and methods for using these cassettes for cryopreserving biomaterials (e.g., a bioengineered construct or natural tissue sample) by vitrification while reducing or preventing the loss of viability associated with conventional preservation methods.
IPC Classes ?
- C12M 1/32 - Inoculator or sampler multiple field or continuous type
- C12M 3/00 - Tissue, human, animal or plant cell, or virus culture apparatus
- C12M 1/12 - Apparatus for enzymology or microbiology with sterilisation, filtration, or dialysis means
|
4.
|
CASSETTE FOR PRESERVATION OF NATURAL AND BIOENGINEERED TISSUES
| Application Number |
17987257 |
| Status |
Pending |
| Filing Date |
2022-11-15 |
| First Publication Date |
2023-05-18 |
| Owner |
TISSUE TESTING TECHNOLOGIES LLC (USA)
|
| Inventor |
- Campbell, Lia H.
- Wright, Gregory J.
- Greene, Elizabeth
- Brockbank, Kelvin G.M.
|
Abstract
Described herein are cassettes and methods for using these cassettes for cryopreserving biomaterials (e.g., a bioengineered construct or natural tissue sample) by vitrification while reducing or preventing the loss of viability associated with conventional preservation methods.
IPC Classes ?
- B01L 3/00 - Containers or dishes for laboratory use, e.g. laboratory glasswareDroppers
- B01L 9/00 - Supporting devicesHolding devices
|
5.
|
PRESERVATION OF NATURAL AND BIOENGINEERED TISSUES AND METHODS OF STORING AND TRANSPORT
| Application Number |
17987404 |
| Status |
Pending |
| Filing Date |
2022-11-15 |
| First Publication Date |
2023-05-18 |
| Owner |
TISSUE TESTING TECHNOLOGIES LLC (USA)
|
| Inventor |
- Campbell, Lia H.
- Brockbank, Kelvin G.M.
|
Abstract
Described herein are methods for preserving biomaterials by vitrification while reducing or preventing the loss of viability associated with conventional preservation methods. Also described herein are cassettes and methods for using these cassettes for cryopreserving biomaterials (e.g., a bioengineered construct or natural tissue sample).
|
6.
|
PRESERVATION METHODS USING TREHALOSE WITH OTHER CRYOPROTECTANTS BEING ABSENT FROM THE CRYOPRESERVATION PROTOCOL
| Application Number |
US2022027248 |
| Publication Number |
2022/235552 |
| Status |
In Force |
| Filing Date |
2022-05-02 |
| Publication Date |
2022-11-10 |
| Owner |
TISSUE TESTING TECHNOLOGIES LLC (USA)
|
| Inventor |
- Brockbank, Kelvin G.M.
- Campbell, Lia H.
|
Abstract
Cellular material containing living cells is preserved by combining the cellular material with a cryoprotectant formulation/medium/solution containing an effective amount of trehalose (in the absence of DMSO and/or any other added cryoprotectants) during a cryopreservation protocol. That is, the cryopreservation protocol is free of cryoprotectant other than trehalose, and the cryopreservation protocol includes: exposing the cellular material to a cryoprotectant formulation containing an effective amount of the trehalose to act as a cryoprotectant, cooling the cellular material at a cooling rate in the range of from ‑3°C/minute to -50°C/minute to a predetermined temperature below -20°C, and obtaining a cryopreserved cellular material that has been warmed.
|
7.
|
PRESERVATION METHODS USING TREHALOSE WITH OTHER CRYOPROTECTANTS BEING ABSENT FROM THE CRYOPRESERVATION PROTOCOL
| Application Number |
17731616 |
| Status |
Pending |
| Filing Date |
2022-04-28 |
| First Publication Date |
2022-11-10 |
| Owner |
TISSUE TESTING TECHNOLOGIES LLC (USA)
|
| Inventor |
- Brockbank, Kelvin G.M.
- Campbell, Lia H.
|
Abstract
Cellular material containing living cells is preserved by combining the cellular material with a cryoprotectant formulation/medium/solution containing an effective amount of trehalose (in the absence of DMSO and/or any other added cryoprotectants) during a cryopreservation protocol. That is, the cryopreservation protocol is free of cryoprotectant other than trehalose, and the cryopreservation protocol includes: exposing the cellular material to a cryoprotectant formulation containing an effective amount of the trehalose to act as a cryoprotectant, cooling the cellular material at a cooling rate in the range of from −3° C./minute to −50° C./minute to a predetermined temperature below −20° C., and obtaining a cryopreserved cellular material that has been warmed.
|
8.
|
MINIMIZING IMMUNOGENICITY OF DECELLULARIZED TISSUES
| Application Number |
US2021055788 |
| Publication Number |
2022/087089 |
| Status |
In Force |
| Filing Date |
2021-10-20 |
| Publication Date |
2022-04-28 |
| Owner |
TISSUE TESTING TECHNOLOGIES LLC (USA)
|
| Inventor |
Brockbank, Kelvin Gm
|
Abstract
A method for preserving and reducing the immunogenicity of a tissue, the method including obtaining a first tissue, the first tissue being a wild type tissue or genetically modified tissue; forming a second tissue by immersing the first tissue in a first solution having a cryoprotectant concentration of at least about 75% by weight for at least one hour to kill and lyse the cells of the first tissue; forming a third tissue by removing residual cell materials of the second tissue, the residual cell materials of the second tissue being removed by subjecting the second tissue to decellularization in a bioreactor; and subjecting the third tissue to ice-free cryopreservation.
IPC Classes ?
- A61L 27/36 - Materials for prostheses or for coating prostheses containing ingredients of undetermined constitution or reaction products thereof
|
9.
|
MINIMIZING IMMUNOGENICITY OF DECELLULARIZED TISSUES
| Application Number |
17506140 |
| Status |
Pending |
| Filing Date |
2021-10-20 |
| First Publication Date |
2022-04-21 |
| Owner |
TISSUE TESTING TECHNOLOGIES LLC (USA)
|
| Inventor |
Brockbank, Kelvin Gm
|
Abstract
A method for preserving and reducing the immunogenicity of a tissue, the method including obtaining a first tissue, the first tissue being a wild type tissue or genetically modified tissue; forming a second tissue by immersing the first tissue in a first solution having a cryoprotectant concentration of at least about 75% by weight for at least one hour to kill and lyse the cells of the first tissue; forming a third tissue by removing residual cell materials of the second tissue, the residual cell materials of the second tissue being removed by subjecting the second tissue to decellularization in a bioreactor; and subjecting the third tissue to ice-free cryopreservation.
|
10.
|
ICE-FREE VITRIFICATION AND NANO-WARMING OF LARGE TISSUE SAMPLES
| Application Number |
US2020058843 |
| Publication Number |
2021/091984 |
| Status |
In Force |
| Filing Date |
2020-11-04 |
| Publication Date |
2021-05-14 |
| Owner |
TISSUE TESTING TECHNOLOGIES LLC (USA)
|
| Inventor |
- Brockbank, Kelvin Gm
- Chen, Zhen Zhen
|
Abstract
Large volume cellular material may be preserved by combining the cellular material with a cryoprotectant formulation/medium/solution containing at least one mNP and then subjecting the cellular material to a vitrification preservation protocol including nanowarming. This preservation method is particularly effective for cartilage tissues and large blood vessels, and includes, for example, exposing the cellular material to a high concentration cryoprotectant formulation containing at least 0.5 mg/mL Fe mNPs, subjecting the cellular material to a preservation protocol in which ice-induced damage to the cellular material does not occur, and obtaining a cryopreserved cellular material that has been nanowarmed; wherein metabolic activity of the nanowarmed tissue is fully recovered to control values within two days of being rewarmed.
|
11.
|
ICE-FREE VITRIFICATION AND NANO WARMING OF LARGE TISSUE SAMPLES
| Application Number |
17088860 |
| Status |
Pending |
| Filing Date |
2020-11-04 |
| First Publication Date |
2021-05-13 |
| Owner |
TISSUE TESTING TECHNOLOGIES LLC (USA)
|
| Inventor |
- Brockbank, Kelvin Gm
- Chen, Zhen Zhen
|
Abstract
Large volume cellular material may be preserved by combining the cellular material with a cryoprotectant formulation/medium/solution containing at least one mNP and then subjecting the cellular material to a vitrification preservation protocol including nanowarming. This preservation method is particularly effective for cartilage tissues.
|
12.
|
Ice-free preservation of large volume tissue samples for viable, functional tissue banking
| Application Number |
15843462 |
| Grant Number |
11246308 |
| Status |
In Force |
| Filing Date |
2017-12-15 |
| First Publication Date |
2018-07-12 |
| Grant Date |
2022-02-15 |
| Owner |
TISSUE TESTING TECHNOLOGIES LLC (USA)
|
| Inventor |
- Brockbank, Kelvin Gm
- Campbell, Lia H.
|
Abstract
Large volume cellular material may be preserved by combining the cellular material with a cryoprotectant formulation/medium/solution containing at least one sugar and then subjecting the cellular material to a vitrification preservation protocol.
|
13.
|
ICE-FREE PRESERVATION OF LARGE VOLUME TISSUE SAMPLES FOR VIABLE, FUNCTIONAL TISSUE BANKING
| Application Number |
US2017067060 |
| Publication Number |
2018/118799 |
| Status |
In Force |
| Filing Date |
2017-12-18 |
| Publication Date |
2018-06-28 |
| Owner |
TISSUE TESTING TECHNOLOGIES LLC (USA)
|
| Inventor |
- Brockbank, Kelvin, Gm.
- Campbell, Lia, H.
|
Abstract
Large volume cellular material may be preserved by combining the cellular material with a cryoprotectant formulation/medium/solution containing at least one sugar and then subjecting the cellular material to a vitrification preservation protocol.
|
14.
|
ENHANCEMENT OF CELL CRYOPRESERVATION WITH GLYCOLIPIDS
| Application Number |
US2017043090 |
| Publication Number |
2018/017843 |
| Status |
In Force |
| Filing Date |
2017-07-20 |
| Publication Date |
2018-01-25 |
| Owner |
TISSUE TESTING TECHNOLOGIES LLC (USA)
|
| Inventor |
- Campbell, Lia H.
- Brockbank, Kelvin G. M.
|
Abstract
The application relates to a method for preserving living cellular material, comprising: exposing a cellular material to medium containing at least one glycolipid and a cryoprotectant for a predetermined amount of time; and after the exposure, subjecting the cellular material to a preservation protocol comprising cryopreservation at a cryopreservation temperature of about -80°C or less.
|
15.
|
Enhancement of cell cryopreservation with glycolipids
| Application Number |
15655381 |
| Grant Number |
10687525 |
| Status |
In Force |
| Filing Date |
2017-07-20 |
| First Publication Date |
2018-01-25 |
| Grant Date |
2020-06-23 |
| Owner |
TISSUE TESTING TECHNOLOGIES LLC (USA)
|
| Inventor |
- Campbell, Lia H.
- Brockbank, Kelvin G M
|
Abstract
Living cellular material may be preserved by incubating the cellular material in a culture medium containing at least one glycolipid, and then subjecting the cellular material to a preservation protocol.
IPC Classes ?
- A01N 1/02 - Preservation of living parts
- C07H 15/06 - Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of a saccharide radical being a hydroxyalkyl group esterified by a fatty acid
|
|